Metabolomics

Dataset Information

0

Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study


ABSTRACT:

Osteoarticular tuberculosis is one of the extrapulmonary tuberculosis, which is mainly caused by direct infection of Mycobacterium tuberculosis or secondary infection of tuberculosis in other parts. Due to the low specificity of the current detection method, it is leading to a high misdiagnosis rate and subsequently affecting the follow-up treatment and prognosis. Metabolomics is mainly used to study the changes of the body's metabolites in different states, so it can be served as an important means in the discovery of disease-related metabolic biomarkers and the corresponding mechanism research. Liquid chromatography tandem mass spectrometry (LC-MS/MS) was used to detect and analyze metabolites in the serum with osteoarticular tuberculosis patients, disease controls and healthy controls to find novel metabolic biomarkers that could be used in the diagnosis of osteoarticular tuberculosis. Our results showed that 68 differential metabolites (p<0.05, Fold Change>1.0) were obtained in osteoarticular tuberculosis serum after statistical analysis. Then, through the evaluation of diagnostic efficacy, PC(o-16:1(9Z)/18:0), PC(20:4(8Z,11Z,14Z,17Z)/18:0), PC(18:0/22:5(4Z,7Z,10Z,13Z,16Z)), SM(d18:1/20:0), and SM(d18:1/18:1(11Z)) were found as potential biomarkers with high diagnostic efficacy. Using bioinformatics analysis, we further found that these metabolites share many lipids metabolic signaling pathways, such as choline metabolism, sphingolipid signaling, retrograde endocannabinoid signaling, sphingolipid and glycerophospholipid, these results suggest that lipid metabolism plays an important role in the pathological process of tuberculosis. This study can provide certain reference value for the study of metabolic biomarkers of osteoarticular tuberculosis and the mechanism of lipid metabolism in osteoarticular tuberculosis and even other tuberculosis diseases.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse phase, Liquid Chromatography MS - positive - hilic, Liquid Chromatography MS - positive - reverse phase

SUBMITTER: Ximeng Chen 

PROVIDER: MTBLS4187 | MetaboLights | 2022-04-08

REPOSITORIES: MetaboLights

Similar Datasets

2024-02-28 | GSE249824 | GEO
2019-05-20 | PXD007158 | Pride
2023-12-25 | GSE146260 | GEO
2018-04-19 | GSE107994 | GEO
2018-04-19 | GSE107993 | GEO
2018-04-19 | GSE107992 | GEO
2018-04-19 | GSE107991 | GEO
2021-09-10 | PXD025150 | Pride
2012-02-27 | E-GEOD-29654 | biostudies-arrayexpress
2011-07-12 | E-GEOD-29676 | biostudies-arrayexpress